Andrew Gaudin Progress made in 2025 Positively influence pending legislative, regulatory and policy change Delivered full mitigation of the potential adverse fee impacts of 12-month prescriptions from 1 February 2026 – avoiding a mid-po... 12-month prescriptions Advocacy Funding NAAR Jan 31, 2026